PB

Pivotal bioVenture Partners China

Asia, Shanghai, China, Shanghai

Description

An Investment Firm based In China.

Investor Profile

Pivotal bioVenture Partners China has made 7 investments, with 0 in the past 12 months and 29% as lead.

Stage Focus

  • Series B (43%)
  • Seed (29%)
  • Series A (29%)

Country Focus

  • China (71%)
  • United States (29%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Life Science
  • Medical
  • Biopharma
  • Medical Device
  • Precision Medicine
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pivotal bioVenture Partners China frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 1
CC
Africa, Rabat-Sale-Zemmour-Zaer, Morocco, Rabat
Co-Investments: 1
CA
North America, Massachusetts, United States, Boston
Co-Investments: 1
Nan Fung Life Sciences
North America, California, United States, San Francisco
Co-Investments: 5
Ascendis Pharma
North America, California, United States, Palo Alto
Co-Investments: 1
Morningside Group
North America, Massachusetts, United States, Newton Center
Co-Investments: 2
Volcanics Venture
Asia, Shanghai, China, Changning
Co-Investments: 2
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 1

Which angels does Pivotal bioVenture Partners China often collaborate with?

Adrian Cheng
Asia, Hong Kong
Shared Deals: 1

What are some of recent deals done by Pivotal bioVenture Partners China?

Heranova Lifesciences

Huangpu, Shanghai, China

Hekaiwei is a provider of innovative solutions for women's health.

Health CareMedical
SeedDec 28, 2023
Amount Raised: $3,500,000
Ablaze Pharmaceuticals

Jingan, Shanghai, China

Ablaze Pharmaceuticals is a clinical-stage pharmaceutical company.

BiotechnologyMedicalPharmaceutical
Series ANov 29, 2021
Amount Raised: $75,000,000
Arctic Vision

Shanghai, Shanghai, China

Arctic Vision is focused on the development and commercialization of innovative ophthalmology therapies.

BiotechnologyHealth CareLife Science
Series BMar 9, 2021
Amount Raised: $100,000,000
Visen Pharmaceuticals

Shanghai, Shanghai, China

Visen Pharmaceuticals is a biotech company focused on developing and commercializing innovative endocrine drugs.

BiotechnologyLife SciencePharmaceutical
Series BJan 8, 2021
Amount Raised: $150,000,000
Arctic Vision

Shanghai, Shanghai, China

Arctic Vision is focused on the development and commercialization of innovative ophthalmology therapies.

BiotechnologyHealth CareLife Science
Series AJul 13, 2020
Amount Raised: $32,000,000
OncXerna Therapeutics

Waltham, Massachusetts, United States

OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.

BiopharmaBiotechnologyHealth CareMedical DevicePharmaceuticalPrecision Medicine
Series BJun 10, 2019
Amount Raised: $80,000,000
OncXerna Therapeutics

Waltham, Massachusetts, United States

OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform.

BiopharmaBiotechnologyHealth CareMedical DevicePharmaceuticalPrecision Medicine
SeedJun 7, 2018
Amount Raised: $16,500,000